Icahn School of Medicine at Mt. Sinai — New York, New York

Icahn School of Medicine at Mt. Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mt. Sinai has participated in 36 clinical trials with 15 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Multiple Myeloma, Multiple Myeloma in Relapse.

Sponsors: Constellation Pharmaceuticals, Fortis Therapeutics, Inc., Embecta Corp..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mt. Sinai?

Icahn School of Medicine at Mt. Sinai has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mt. Sinai conducted?

Icahn School of Medicine at Mt. Sinai has 36 clinical trials on record, with 15 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Multiple Myeloma, Multiple Myeloma in Relapse.

Is Icahn School of Medicine at Mt. Sinai accredited by Crixeo Health?

Icahn School of Medicine at Mt. Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mt. Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.